Renal

Top Story

Renal denervation safely reduces BP in absence of antihypertensive medications

Renal denervation safely reduces BP in absence of antihypertensive medications
March 29, 2020

Read the Perspective from Ashish Pershad, MD

Meeting News

DCB remains superior to PTA at 1 year in treatment of arteriovenous fistula lesions

February 6, 2020
A drug-coated balloon was superior to percutaneous transluminal angioplasty at 1 year for primary patency and clinically driven target lesion revascularization in…
In the Journals

Catheter ablation with renal denervation may eliminate AF at 12 months

January 21, 2020
Renal denervation with catheter ablation in patients with paroxysmal atrial fibrillation and hypertension significantly increased the likelihood of freedom from AF at 12…
FDA News

FDA approves Medtronic drug-coated balloon to treat failing arteriovenous access in dialysis

November 21, 2019
Medtronic plc has received approval from the FDA for its IN.PACT AV drug-coated balloon, which was designed to prevent vessel restenosis, thereby enabling arteriovenous…
More Headlines »
The Take Home

The Take Home: EuroPCR

Cardiology Today's Intervention, July/August 2018
Some of the hottest topics in interventional cardiology, from physiologic assessment to renal denervation, were…
More »
Video
Meeting News

VIDEO: New insights on renal denervation, top research from TCT 2018

October 13, 2018
More »
Meeting News

DCB bests PTA in patency during treatment of arteriovenous fistula lesions

September 10, 2019
A drug-coated balloon yielded superior patency to percutaneous transluminal angioplasty in patients with de novo or…
More »